Kris Sachsenmeier

Summary

Affiliation: MedImmune Vaccines
Country: USA

Publications

  1. doi request reprint Development of a novel ectonucleotidase assay suitable for high-throughput screening
    KRIS F SACHSENMEIER
    MedImmune, LLC, Gaithersburg, MD, USA
    J Biomol Screen 17:993-8. 2012
  2. pmc Combining phenotypic and proteomic approaches to identify membrane targets in a 'triple negative' breast cancer cell type
    Steven Rust
    MedImmune, Granta Park, Cambridge, CB21 6GH, UK
    Mol Cancer 12:11. 2013

Collaborators

  • Steven Rust
  • Erin Brand
  • Carl Hay
  • Robert Hollingsworth
  • Anders Karlsson
  • Max Davidson
  • John Elvin
  • Gene Kurosawa
  • Sandrine Guillard
  • Matt Flynn
  • Ralph Minter
  • Lutz Jermutus
  • Roger Karlsson
  • David Lowne

Detail Information

Publications2

  1. doi request reprint Development of a novel ectonucleotidase assay suitable for high-throughput screening
    KRIS F SACHSENMEIER
    MedImmune, LLC, Gaithersburg, MD, USA
    J Biomol Screen 17:993-8. 2012
    ..This multiwell plate-based assay facilitates the screening of potential ectonucleotidase antagonists and is unaffected by the presence of contaminating phosphate molecules present in screening samples...
  2. pmc Combining phenotypic and proteomic approaches to identify membrane targets in a 'triple negative' breast cancer cell type
    Steven Rust
    MedImmune, Granta Park, Cambridge, CB21 6GH, UK
    Mol Cancer 12:11. 2013
    ..In this study, the MDA-MB-231 cell line was selected for membranome survey as it is a 'triple negative' breast cancer cell line, which represents a cancer subtype that is aggressive and has few treatment options...